Improving the Antigenicity of SARS-CoV-2 Vaccine Genes by Merging Mutations from Different Variants of Concern

被引:0
|
作者
Herwig, Susanne [1 ,2 ,3 ]
Adler, Julia M. [4 ]
Vladimirova, Daria [4 ]
Trimpert, Jakob [4 ]
Sehouli, Jalid [1 ,2 ,3 ]
Cichon, Guenter [1 ,2 ,3 ]
机构
[1] Charite Univ Med Berlin, Dept Gynecol, D-10117 Berlin, Germany
[2] Free Univ Berlin, D-10117 Berlin, Germany
[3] Humboldt Univ, D-10117 Berlin, Germany
[4] Free Univ Berlin, Inst Virol, D-14163 Berlin, Germany
关键词
SARS-CoV-2; vaccine; neutralizing antibodies; mutations; vaccine genes; cross protection;
D O I
10.3390/vaccines12030248
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During the COVID-19 pandemic, the early emergence of viral variants repeatedly undermined the effects of vaccination. Our aim here is to explore strategies for improving spike vaccine gene antigenicity by merging mutations from different variants of concern (VOCs) in a single vaccine gene. To this end, newly developed recombinant vaccine genes were designed, cloned into adenoviral vectors, and applied to C57BL/6 mice; then, serum-neutralizing antibodies against the wildtype SARS-CoV-2 strains were determined in neutralization assays. The merger of mutations from different variants of concern (alpha, beta, gamma, and delta) in a single recombinant spike-based vaccine gene provided a substantial improvement in neutralizing immunity to all variants of concern, including the omicron strains. To date, only unmodified spike genes of the original SARS-CoV-2 Wuhan strain (B.1) or dominant variants (BA.1, BA.5, and XBB.1.5) have been used as vaccine genes. The employment of unmodified vaccine genes is afflicted by limited cross-protection among variant strains. In contrast, recombinant vaccine genes that combine mutations from different strains in a single gene hold the potential to broaden and improve immune protection and might help to reduce the need for frequent vaccine adaptations in the future.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
    Hu, Ye-Fan
    Hu, Jing-Chu
    Gong, Hua-Rui
    Danchin, Antoine
    Sun, Ren
    Chu, Hin
    Hung, Ivan Fan-Ngai
    Yuen, Kwok Yung
    To, Kelvin Kai-Wang
    Zhang, Bao-Zhong
    Yau, Thomas
    Huang, Jian-Dong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] The SARS-CoV-2 variants of concern
    Passi, Gouri Rao
    INDIAN PEDIATRICS, 2021, 58 (05) : 498 - 498
  • [3] SARS-CoV-2 Variants of Concern
    Choi, Jun Yong
    Smith, Davey M.
    YONSEI MEDICAL JOURNAL, 2021, 62 (11) : 961 - 968
  • [4] Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
    Josephine Wambani
    Patrick Okoth
    The Egyptian Journal of Internal Medicine, 2022, 34 (1)
  • [5] SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern
    Ji Yun Noh
    Hye Won Jeong
    Eui-Cheol Shin
    Signal Transduction and Targeted Therapy, 6
  • [6] SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern
    Noh, Ji Yun
    Jeong, Hye Won
    Shin, Eui-Cheol
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [7] SARS-CoV-2 variants of concern and vaccine escape, from Alpha to Omicron and beyond
    Ong, Sean Wei Xiang
    Chia, Travis
    Young, Barnaby Edward
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2022, 16 (05) : 499 - 502
  • [8] Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India
    Singh, Urvashi B.
    Rophina, Mercy
    Chaudhry, Rama
    Senthivel, Vigneshwar
    Bala, Kiran
    Bhoyar, Rahul C.
    Jolly, Bani
    Jamshed, Nayer
    Imran, Mohamed
    Gupta, Ritu
    Aggarwal, Praveen
    Divakar, Mohit K.
    Sinha, Subrata
    Arvinden, V. R.
    Bajaj, Anjali
    Shamnath, Afra
    Jain, Abhinav
    Scaria, Vinod
    Sivasubbu, Sridhar
    Guleria, Randeep
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (04) : 1696 - 1700
  • [9] The emerging SARS-CoV-2 variants of concern
    Sanyaolu, Adekunle
    Okorie, Chuku
    Marinkovic, Aleksandra
    Haider, Nafees
    Abbasi, Abu Fahad
    Jaferi, Urooj
    Prakash, Stephanie
    Balendra, Vyshnavy
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [10] The origin of SARS-CoV-2 variants of concern
    Burki, Talha
    LANCET INFECTIOUS DISEASES, 2022, 22 (02): : 174 - 175